Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis
- 14 March 2001
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 7 (2), 133-139
- https://doi.org/10.1046/j.1365-2516.2001.00465.x
Abstract
The aims of this study were to investigate possible age‐related changes in the disposition of factor IX procoagulant activity (FIX:C) after administration of recombinant factor IX (rFIX) and to trans...Keywords
This publication has 12 references indexed in Scilit:
- Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxisHaemophilia, 1998
- Call for post‐licensing human pharmacokinetic studies of administration of recombinant factor IXHaemophilia, 1998
- Improved cost‐effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia AHaemophilia, 1997
- The pharmacokinetics of factor VIII and factor IX: methodology, pitfalls and applicationsHaemophilia, 1997
- Recombinant Factor IXThrombosis and Haemostasis, 1997
- Pharmacokinetics of factor IX in patients with haemophilia BEuropean Journal of Clinical Pharmacology, 1994
- Pharmacokinetic dosing in prophylactic treatment of hemophilia AEuropean Journal of Haematology, 1993
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992
- Should clearance be normalised to body surface or to lean body mass?British Journal of Clinical Pharmacology, 1981
- ANTHROPOMETRIC EVALUATION OF BODY COMPOSITION THROUGHOUT LIFEAnnals of the New York Academy of Sciences, 1963